FMA
ABBV icon

FNY Managed Accounts’s AbbVie ABBV Stock Holding History

FNY Managed Accounts’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-168
Closed -$10K – 169
2017
Q1 		$10K Buy
+168
New +$10.6K 0.03% 483
2014
Q1 		– Sell
-1,000
Closed -$53K – 121
2013
Q4 		$53K Buy
+1,000
New +$49.1K 0.08% 113

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FNY Managed Accounts's ABBV Position: Q2 2017 in Review

FNY Managed Accounts sold out of AbbVie (ABBV) in Q2 2017, closing a stake of 168 shares — an estimated $10K sold.

FNY Managed Accounts first reported a position in ABBV in Q4 2013 and held it in 2 quarters. The position peaked at $53K in Q4 2013. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • FNY Managed Accounts reported no remaining AbbVie position as of Q2 2017 after selling out during the quarter.
  • FNY Managed Accounts sold 168 AbbVie shares in Q2 2017, an estimated $10K.
  • FNY Managed Accounts first reported a position in AbbVie in Q4 2013 and held it in 2 quarters.
  • FNY Managed Accounts's AbbVie position peaked at $53K in Q4 2013.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.